NVLPF (Nova Leap Health) Beneish M-Score: -2.64 (As of Jun. 25, 2026)


NVLPF Nova Leap Health Corp NVLPF
50 GF Score
Price $0.25
GF Value $0.19
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nova Leap Health Beneish M-Score?

Nova Leap Health NVLPF 50 Beneish M-Score is -2.64 as of Jun. 25, 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.19 (Fairly Valued). The stock has 4 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Nova Leap Health ranks better than 55.06% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.64 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Nova Leap Health's Beneish M-Score or its related term are showing as below:

NVLPF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.41   Med: -2.67   Max: 41.34
Current: -2.64

During the past 10 years, the highest Beneish M-Score of Nova Leap Health was 41.34. The lowest was -3.41. And the median was -2.67.

Nova Leap Health Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Nova Leap Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Leap Health Beneish M-Score Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.80 -2.92 -2.99 -2.75 -2.64

Nova Leap Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.77 -2.84 -2.77 -2.64 -2.64

NVLPF vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Nova Leap Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Leap Health Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's Beneish M-Score falls into.


NVLPF
50GF Score
Nova Leap Health Corp NVLPF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Leap Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Nova Leap Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8651+0.528 * 0.969+0.404 * 0.9856+0.892 * 1.2194+0.115 * 0.8611
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9978+4.679 * -0.041302-0.327 * 0.8638
=-2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $1.82 Mil.
Revenue was 7.852 + 8.088 + 8.264 + 8.021 = $32.23 Mil.
Gross Profit was 3.132 + 3.221 + 3.273 + 3.224 = $12.85 Mil.
Total Current Assets was $3.73 Mil.
Total Assets was $23.44 Mil.
Property, Plant and Equipment(Net PPE) was $0.91 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.79 Mil.
Selling, General, & Admin. Expense(SGA) was $10.74 Mil.
Total Current Liabilities was $3.65 Mil.
Long-Term Debt & Capital Lease Obligation was $0.70 Mil.
Net Income was 0.325 + -0.054 + 0.426 + -0.484 = $0.21 Mil.
Non Operating Income was 0.242 + -0.247 + 0.252 + -0.822 = $-0.58 Mil.
Cash Flow from Operations was 0.396 + 0.277 + 0.471 + 0.612 = $1.76 Mil.
 Total Receivables was $1.73 Mil.
Revenue was 7.094 + 6.586 + 6.407 + 6.339 = $26.43 Mil.
Gross Profit was 2.767 + 2.574 + 2.434 + 2.436 = $10.21 Mil.
Total Current Assets was $3.37 Mil.
Total Assets was $23.19 Mil.
Property, Plant and Equipment(Net PPE) was $0.95 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.63 Mil.
Selling, General, & Admin. Expense(SGA) was $8.83 Mil.
Total Current Liabilities was $4.13 Mil.
Long-Term Debt & Capital Lease Obligation was $0.86 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.824 / 32.225) / (1.729 / 26.426)
=0.056602 / 0.065428
=0.8651

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(10.211 / 26.426) / (12.85 / 32.225)
=0.3864 / 0.398759
=0.969

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3.732 + 0.906) / 23.437) / (1 - (3.371 + 0.946) / 23.19)
=0.802108 / 0.813842
=0.9856

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=32.225 / 26.426
=1.2194

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.63 / (0.63 + 0.946)) / (0.785 / (0.785 + 0.906))
=0.399746 / 0.464222
=0.8611

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(10.743 / 32.225) / (8.829 / 26.426)
=0.333375 / 0.334103
=0.9978

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.7 + 3.653) / 23.437) / ((0.858 + 4.128) / 23.19)
=0.185732 / 0.215006
=0.8638

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(0.213 - -0.575 - 1.756) / 23.437
=-0.041302

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Nova Leap Health has a M-score of -2.59 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.64 mean?
Nova Leap Health (NVLPF) has a Beneish M-Score of -2.64 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Nova Leap Health and its competitors. According to the industry distribution chart, Nova Leap Health ranks #284 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 44.9%.
Is Nova Leap Health's Beneish M-Score too high?
Nova Leap Health's current Beneish M-Score is -2.64. Based on the distribution chart, Nova Leap Health ranks #284 out of 632 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #284 out of 632 companies for Beneish M-Score. This puts Nova Leap Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Nova Leap Health and its competitors. Nova Leap Health's current Beneish M-Score is -2.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.19, compared to a current price of $0.25 — trading 29.7% above its estimated fair value. The current Beneish M-Score is -2.64. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Beneish M-Score is -2.64 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova Leap Health (NVLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued. The current stock price of $0.25 is trading 29.7% above its estimated GF Value™ of $0.19. GuruFocus considers Nova Leap Health to be Fairly Valued.

Key valuation signals for NVLPF:

  • Beneish M-Score: -2.64
  • GF Value™: $0.19 vs. price of $0.25 (29.7% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nova Leap Health Business Description

Other Exchanges NLH:Canada
Address 7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score

Get the complete analysis for NVLPF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price
$0.19
GF Value